The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

Saudi-based Sudair Pharma Company is set to establish its new insulin plant in the Sudair City for Industry and Businesses.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...

For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

Trump's threat of imposing a tariff on Denmark over desires to acquire Greenland has caught the attention of one of the ...

With a biochemicals portfolio that aligns with Chinese development priorities, the company’s future in the local biotech ...

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

President Trump has said he plans to raise or impose new tariffs on a wide range of products, including pharmaceuticals. While Trump has openly discussed rolling out tariffs on China, Mexico and ...

Eli Lilly and Novo Nordisk, can’t keep up with the demand for them. People who were morbidly obese or just slightly overweight suddenly saw the possibility that they could have the svelte body image ...